183
Participants
Start Date
August 31, 2007
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
Placebo
2 capsules, once a day for 8 weeks
MBX-8025
2 capsules, once daily for 8 weeks
MBX-8025
2 capsule, once daily for 8 weeks
Atorvastatin
2 capsules, once daily for 8 weeks
MBX-8025
2 capsules, once daily for 8 weeks
MBX-8025
2 capsules, once daily for 8 weeks
United Medical Associates P.C., Binghamton
Southgate Medical Group, West Seneca
Rochester Clinical Research, Rochester
Great Lakes Medical Research, Westfield
PHA-Adult Medicine, Philadelphia
Health Trends Research LLC, Baltimore
Piedmont Medical Research Associates, Winston-Salem
PharmQuest, Greensboro
Crescent Medical Research, Salisbury
Radiant Research, Greer
Radiant Research, Birmingham
Tricities Medical Research, Bristol
Holston Medical Group Clinical Research, Kingsport
L-Marc Research Center, Louisville
Genesis Research International, Indianapolis
Midwest Institute for Clinical Research Inc., Indianapolis
Maine Research Associates, Auburn
Troy Internal Medicine Research, Troy
Dallas Diabetes and Endocrine Center, Dallas
Diabetes and Glandular Disease Research, San Antonio
Anasazi Internal Medicine Research, Phoenix
Rochester Clinical Research, Albuquerque
Diabetes/Lipid Management and Research Center, Huntington Beach
Radiant Research, Santa Rosa
Walla Walla Clinic, Walla Walla
Clinical Research Consulting LLC, Milford
Bridgewater Medical Group, Bridgewater
Clifton-Wallington Medical Group, Clifton
Lead Sponsor
Gilead Sciences
INDUSTRY